• Teva Pharmaceutical Industries Ltd., of Petach Tikva, Israel, said that the U.S. District Court for the District of New Jersey gave it a favorable ruling in a patent infringement lawsuit against Mylan related to Azilect (rasagiline tablets) for Parkinson’s disease.